Skip to main content
  • English
  • Català
  • Español
Home
  • Company
    • Overview & History
    • Team
    • Join Oryzon
  • Epigenetics
    • Histone Code Hypothesis
    • Modulator Enzymes
    • LSD1 & Disease
    • Technology Platforms
    • Scientific Publications by Oryzon
  • Therapeutic Programs
    • Strategy
    • LSD1 & Cancer
    • Oryzon's Pipeline
  • Collaborative Research
    • Collaborative Projects
  • For Patient
    • Patient Information
  • Shareholders and Investors
    • Investor Information and News
    • Share Information
    • Events & Presentations
    • Financial Information & Downloads
    • Analyst Coverage
    • Corporate Governance
    • Corporate Social Responsibility
  • News & Press Releases
  • Contact
    • General Contact
    • Investor Contact
    • Email Alerts

investors

Shareholders and Investors

  • Investor Information and News
  • Share Information
  • Events & Presentations
  • Financial Information & Downloads
  • Analyst Coverage
  • Corporate Governance
  • Corporate Social Responsibility

Corporate Social Responsibility

Corporate Social Responsibility Principles

 

Annual Reports on Corporate Social Responsibility Policy

Date Title
February 2019 Annual Report on Corporate Social Responsibility Policy 2018 (Spanish only)
February 2018 Annual Report on Corporate Social Responsibility Policy 2017 (Spanish only)
February 2017 Annual Report on Corporate Social Responsibility Policy 2016 (Spanish only)
February 2016 Annual Report on Corporate Social Responsibility Policy 2015 (Spanish only)

 


- Compliance Policy.

 

Compliance Policy (Spanish)

 


- Code of Ethics and Conduct.

 

Code of Ethics and Conduct

 


- Whistleblower.

 

Whistleblower Policy

Whistleblower Form (Spanish)

 

  • Español

epigen-logo

Epigenetic drugs for a better world.

United States

Oryzon Corporate
245 First Street, Suite 1800
Cambridge, MA 02142

T: (617) 444-8786
F: (617) 444- 8405
info@oryzon.com

Spain

Oryzon Genomics
Sant Ferran 74
08940 Cornellà de Llobregat, Barcelona, Spain

T: (+34) 93 515 1313
F: (+34) 93 377 4028
info@oryzon.com

Legal Advice
Privacy Policy

Investor Information

ISIN: ES0167733015 - ORY

Please contact us for investor information.

Contact Us

© 2019

Oryzon Genomics

All Rights Reserved

  • Legal Advice
  • Privacy Policy
  • Registered address: Carrera de San Jerónimo 15, 2ª planta, 28014 Madrid (Spain)